Search alternatives:
na decrease » nn decrease (Expand Search), pa decreased (Expand Search), la decreased (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 nm » 10 nm (Expand Search), 12 mm (Expand Search), 12 m (Expand Search)
Showing 1,141 - 1,160 results of 28,654 for search '(( 50 ((na decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 12 nm decrease ))', query time: 0.94s Refine Results
  1. 1141
    EQI decreases malonyl-CoA levels in <i>S</i>. <i>aureus</i>.

    EQI decreases malonyl-CoA levels in <i>S</i>. <i>aureus</i>. by Erica C. Larson (1344687)

    Published 2020
    Save to List
    Saved in:
  2. 1142
    Fig 13 -

    Fig 13 - by Jianbo Jia (717814)

    Published 2024
    Save to List
    Saved in:
  3. 1143
    Participants with virologic suppression or failure at week 24.

    Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1144
    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART.

    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1145
    Consolidated Standards of Reporting Trials flow diagram for participants in the trial.

    Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1146
    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model.

    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1147
    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24.

    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1148
    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1149
    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1150
    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24.

    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1151
    Fig 6 -

    Fig 6 - by Felix Bosch (10024550)

    Published 2021
    Save to List
    Saved in:
  12. 1152
    Fig 5 -

    Fig 5 - by Felix Bosch (10024550)

    Published 2021
    Save to List
    Saved in:
  13. 1153
    Cell proliferation assay.

    Cell proliferation assay. by Jin Zhu (164147)

    Published 2014
    Save to List
    Saved in:
  14. 1154
    Appearance and RF values of samples under UV 365 nm in various fractions.

    Appearance and RF values of samples under UV 365 nm in various fractions. by Asif Khan (1740271)

    Published 2024
    Save to List
    Saved in:
  15. 1155
    Pharmacological inhibition and/or siRNA silencing of EP2 receptor in EP2S cells decrease claudin-4 expression.

    Pharmacological inhibition and/or siRNA silencing of EP2 receptor in EP2S cells decrease claudin-4 expression. by Manigandan Lejeune (458492)

    Published 2014
    Save to List
    Saved in:
  16. 1156
    Effect of cilostazol on liver TNF-α (A), IL-6 (B), NFκβ (C) and TGFβ (D) in TAA-induced fibrosis in rats.

    Effect of cilostazol on liver TNF-α (A), IL-6 (B), NFκβ (C) and TGFβ (D) in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)

    Published 2019
    Save to List
    Saved in:
  17. 1157
    Mean CBD concentration (%) for duration of vegetative phase (DVP) and inflorescence fraction.

    Mean CBD concentration (%) for duration of vegetative phase (DVP) and inflorescence fraction. by Torsten Schober (20485754)

    Published 2024
    Save to List
    Saved in:
  18. 1158
    Mental health group common bigram words (Top 50) before and after pandemic.

    Mental health group common bigram words (Top 50) before and after pandemic. by Yuxuan Cai (19226202)

    Published 2024
    Save to List
    Saved in:
  19. 1159
    50 WT 5′ and 3′ terminal nts of the S1 gene are sufficient to package a non-MRV gene into infectious virions.

    50 WT 5′ and 3′ terminal nts of the S1 gene are sufficient to package a non-MRV gene into infectious virions. by Debarpan Dhar (724473)

    Published 2024
    Save to List
    Saved in:
  20. 1160
    Fluorescence excitation spectra of human insulin (emission fixed at 303 nm) upon prolonged 276 nm UV-excitation.

    Fluorescence excitation spectra of human insulin (emission fixed at 303 nm) upon prolonged 276 nm UV-excitation. by Manuel Correia (113666)

    Published 2012
    Save to List
    Saved in:

Search Tools: